Martell Bridget A 4
4 · Aligos Therapeutics, Inc. · Filed Jun 28, 2024
Insider Transaction Report
Form 4
Martell Bridget A
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-27+60,000→ 60,000 totalExercise: $0.38Exp: 2034-06-27→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2025 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date.